Heavy alcohol use and premature death from hepatocellular carcinoma in the United States, 1999-2006

Journal of Studies on Alcohol and Drugs

Volumn 72, Issue 6, 2011, Pages 892-902

  Dong, Chuanhui ^a   Yoon, Young Hee ^a   Chen, Chiung M ^a   Hsiao Ye, Yi ^a  

^a CSR INCORPORATED   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80755130275     PISSN: 19371888     EISSN: 19384114     Source Type: Journal    
DOI: 10.15288/jsad.2011.72.892     Document Type: Article

References (57)

1. Altekruse, S. F., McGlynn, K. A., & Reichman, M. E. (2009). Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. Journal of Clinical Oncology, 27, 1485-1491.
2. Armstrong, G. L., Wasley, A., Simard, E. P., McQuillan, G. M., Kuhnert, W. L., & Alter, M. J. (2006). The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Annals of Internal Medicine, 144, 705-714.
3. Bagnardi, V., Blangiardo, M., La Vecchia, C., & Corrao, G. (2001). Alcohol consumption and the risk of cancer: A meta-analysis. Alcohol Research & Health, 25, 263-270.
4. Becker, U., Deis, A., Sorensen, T. I., Gronbaek, M., Borch-Johnsen, K., Müller, C. F., Jensen, G. (1996). Prediction of risk of liver disease by alcohol intake, sex, and age: A prospective population study. Hepatology, 23, 1025-1029.
5. Boffetta, P., & Hashibe, M. (2006). Alcohol and cancer. The Lancet Oncology, 7, 149-156.
6. Brooks, P. J., & Theruvathu, J. A. (2005). DNA adducts from acetaldehyde: Implications for alcohol-related carcinogenesis. Alcohol, 35, 187-193.
7. Chen, C. M., Yoon, Y.-H., Yi, H.-Y., & Lucas, D. L. (2007). Alcohol and hepatitis C mortality among males and females in the United States: A life table analysis. Alcoholism: Clinical and Experimental Research, 31, 285-292.
8. Das, S. K., & Vasudevan, D. M. (2007). Alcohol-induced oxidative stress. Life Sciences, 81, 177-187.
9. Davila, J. A., & El-Serag, H. B. (2006). Racial differences in survival of hepatocellular carcinoma in the United States: A population-based study. Clinical Gastroenterology and Hepatology, 4, 104-110, quiz 4-5.
10. DiPadova, C., Worner, T. M., Julkunen, R. J., & Lieber, C. S. (1987). Effects of fasting and chronic alcohol consumption on the first-pass metabolism of ethanol. Gastroenterology, 92, 1169-1173.
11. El-Serag, H. B. (2004). Hepatocellular carcinoma: Recent trends in the United States. Gastroenterology, 127, S27-S34.
12. El-Serag, H. B., Marrero, J. A., Rudolph, L., & Reddy, K. R. (2008). Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology, 134, 1752-1763.
13. El-Serag, H. B., & Mason, A. C. (1999). Rising incidence of hepatocellular carcinoma in the United States. The New England Journal of Medicine, 340, 745-750.
14. Freeman, T. L., Tuma, D. J., Thiele, G. M., Klassen, L. W., Worrall, S., Niemelä, O., Preedy, V. R. (2005). Recent advances in alcoholinduced adduct formation. Alcoholism: Clinical and Experimental Research, 29, 1310-1316.
15. Frezza, M., di Padova, C., Pozzato, G., Terpin, M., Baraona, E., & Lieber, C. S. (1990). High blood alcohol levels in women-The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. New England Journal of Medicine, 322, 95-99.
16. Friedman, S. L. (2008). Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver. Physiological Reviews, 88, 125-172.
17. García-Samaniego, J., Rodríguez, M., Berenguer, J., Rodríguez-Rosado, R., Carbó, J., Asensi, V., & Soriano, V. (2001). Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. American Journal of Gastroenterology, 96, 179-183.
18. Grant, B. F., Dawson, D. A., Stinson, F. S., Chou, S. P., Dufour, M. C., & Pickering, R. P. (2004). The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002. Drug and Alcohol Dependence, 74, 223-234.
19. Graubard, B. I., & Korn, E. L. (1999). Predictive margins with survey data. Biometrics, 55, 652-659.
20. Hanzlick, R. (1988). Death certificates, natural death, and alcohol. The problem of underreporting. American Journal of Forensic Medicine and Pathology, 9, 149-150.
21. Harrison, L. E., Reichman, T., Koneru, B., Fisher, A., Wilson, D., Dela Torre, A., Korogodsky, M. (2004). Racial discrepancies in the outcome of patients with hepatocellular carcinoma. Archives of Surgery, 139, 992-996.
22. Hassan, M. M., Hwang, L.-Y., Hatten, C. J., Swaim, M., Li, D., Abbruzzese, J. L., Patt, Y. Z. (2002). Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology, 36, 1206-1213.
23. Heron, M., Hoyert, D. L., Murphy, S. L., Xu, J., Kochanek, K. D., & Tejada- Vera, B. (2009). Deaths: Final data for 2006. National Vital Statistics Reports, 57(14), Hyattsville, MD: National Center for Health Statistics. Available at http://www.cdc.gov/nchs/data/nvsr/nvsr57/nvsr57_14.pdf
24. Ikejima, K., Enomoto, N., Iimuro, Y., Ikejima, A., Fang, D., Xu, J., Thurman, R. G. (1998). Estrogen increases sensitivity of hepatic Kupffer cells to endotoxin. American Journal of Physiology, 274, G669-G676.
25. Ingram, D. D., Parker, J. D., Schenker, N., Weed, J. A., Hamilton, B., Arias, E., & Madans, J. H. (2003). United States Census 2000 population with bridged race categories (DHHS Publication No. PHS 2003-1335).
26. Vital Health Stat 2 (135). Hyattsville, MD: National Center for Health Statistics. Available at http://www.cdc.gov/nchs/data/series/sr_02/sr02_135.pdf
27. Kim, W. R., Gores, G. J., Benson, J. T., Therneau, T. M., & Melton, L. J., III. (2005). Mortality and hospital utilization for hepatocellular carcinoma in the United States. Gastroenterology, 129, 486-493.
28. Kwo, P. Y., Ramchandani, V. A., O'Connor, S., Amann, D., Carr, L. G., Sandrasegaran, K.,.Li, T.-K. (1998). Gender differences in alcohol metabolism: Relationship to liver volume and effect of adjusting for body mass. Gastroenterology, 115, 1552-1557.
29. Li, T.-K., Beard, J. D., Orr, W. E., Kwo, P. Y., Ramchandani, V. A., & Thomasson, H. R. (2000). Variation in ethanol pharmacokinetics and perceived gender and ethnic differences in alcohol elimination. Alcoholism: Clinical and Experimental Research, 24, 415-416.
30. Lieber, C. S. (2000). Ethnic and gender differences in ethanol metabolism. Alcoholism: Clinical and Experimental Research, 24, 417-418.
31. Manos, M. M., Leyden, W. A., Murphy, R. C., Terrault, N. A., & Bell, B. P. (2008). Limitations of conventionally derived chronic liver disease mortality rates: Results of a comprehensive assessment. Hepatology, 47, 1150-1157.
32. Michielsen, P. P., Francque, S. M., & van Dongen, J. L. (2005). Viral hepatitis and hepatocellular carcinoma. World Journal of Surgical Oncology, 3(1), 27. Available at http://www.wjso.com/content/3/1/27
33. Mueller, S., Millonig, G., & Seitz, H. K. (2009). Alcoholic liver disease and hepatitis C: A frequently underestimated combination. World Journal of Gastroenterology, 15, 3462-3471.
34. Müller, C. (2006). Liver, alcohol and gender. Wiener Medizinische Wochenschrift, 156, 523-526.
35. National Center for Health Statistics. (2004). Bridged-race intercensal estimates for July 1, 1990-July 1, 1999, United States resident population by county, single-year of age, sex, race, and Hispanic origin. Prepared by the U.S. Census Bureau with support from the National Cancer Institute. Available at http://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm#july1999
36. National Center for Health Statistics. (2008). Postcensal estimates of the resident population of the United States for July 1, 2000-July 1, 2007, by year, county, age, bridged race, Hispanic origin, and sex (Vintage 2007). Prepared under a collaborative arrangement with the U.S. Census Bureau; released August 7, 2008. Available at http://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm#vintage2007
37. National Center for Health Statistics. (2010). Instructions for classifying the underlying cause-of-death, ICD-10: Part 2a. Available at http://www.cdc.gov/nchs/data/dvs/2A_2010acc.pdf
38. Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2001). Estimating the world cancer burden: Globocan 2000. International Journal of Cancer, 94, 153-156.
39. Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005). Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians, 55, 74-108.
40. Pollock, D. A., Boyle, C. A., DeStefano, F., Moyer, L. A., & Kirk, M. L. (1987). Underreporting of alcohol-related mortality on death certificates of young US Army veterans. Journal of the American Medical Association, 258, 345-348.
41. Raoul, J. L. (2008). Natural history of hepatocellular carcinoma and current treatment options. Seminars in Nuclear Medicine, 38, S13-S18.
42. Redelings, M. D., Wise, M., & Sorvillo, F. (2007). Using multiple cause-ofdeath data to investigate associations and causality between conditions listed on the death certificate. American Journal of Epidemiology, 166, 104-108.
43. Research Triangle Institute. (2008). SUDAAN: Software for the Statistical Analysis of Correlated Data, Version 10. Research Triangle Park, NC.
44. Schafer, D. F., & Sorrell, M. F. (1999). Hepatocellular carcinoma. The Lancet, 353, 1253-1257.
45. Seitz, H. K., & Becker, P. (2007). Alcohol metabolism and cancer risk. Alcohol Research & Health, 30, 38-41, 44-47.
46. Selvin, S. (1996). Statistical analysis of epidemiologic data (2nd ed.). New York, NY: Oxford University Press.
47. Singal, A. K., & Anand, B. S. (2007). Mechanisms of synergy between alcohol and hepatitis C virus. Journal of Clinical Gastroenterology, 41, 761-772.
48. Spiegelman, D., & Hertzmark, E. (2005). Easy SAS calculations for risk or prevalence ratios and differences. American Journal of Epidemiology, 162, 199-200.
49. Sugimachi, K., Tanaka, S., Taguchi, K., Aishima, S., Shimada, M., & Tsuneyoshi, M. (2003). Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma. Journal of Clinical Pathology, 56, 854-860.
50. Taylor, J. L., Dolhert, N., Friedman, L., Mumenthaler, M., & Yesavage, J. A. (1996). Alcohol elimination and simulator performance of male and female aviators: A preliminary report. Aviation, Space, and Environmental Medicine, 67, 407-413.
51. Thomasson, H. (2000). Alcohol elimination: Faster in women? Alcoholism: Clinical and Experimental Research, 24, 419-420.
52. Thomasson, H. R. (1995). Gender differences in alcohol metabolism. Physiological responses to ethanol. In M. Galanter (Ed.), Recent developments in alcoholism. Volume 12, Alcoholism and Women (pp. 163-179). New York, NY: Plenum Press.
53. Tuma, D. J., & Casey, C. A. (2003). Dangerous byproducts of alcohol breakdown- focus on adducts. Alcohol Research & Health, 27, 285-290.
54. Voigt, M. D. (2005). Alcohol in hepatocellular cancer. Clinics in Liver Disease, 9, 151-169.
55. Wong, R., & Corley, D. A. (2008). Racial and ethnic variations in hepatocellular carcinoma incidence within the United States. American Journal of Medicine, 121, 525-531.
56. World Health Organization. (1992). International classification of diseases and related health problems, tenth revision. Geneva, Switzerland: Author.
57. Yu, M. C., Yuan, J.-M., & Lu, S. C. (2008). Alcohol, cofactors and the genetics of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology, 23, Supplement s1, S92-S97.